Evidence map›Paper›PMID 24152909›Full record

ArticleBMB reports2013

Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9.

Bo-Mi Hwang, Hee Suk Chae, Young-Ju Jeong, Young-Rae Lee, Eun-Mi Noh, Hyun Zo Youn, Sung Hoo Jung, Hong-Nu Yu, Eun Yong Chung, Jong-Suk Kim

Open access · goldAbstract read
In one paragraph

Article in BMB reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  2. Article
  3. Article
  4. Article
  5. The correlation of PTPN4 expression with prognosis in breast cancer.International journal of clinical and experimental pathology · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Bo-Mi HwangDepartments of Biochemistry, Chonbuk National University Medical School, Jeonju 560-756, Korea jsukim@chonbuk.ac.kr.
Hee Suk Chae
Young-Ju Jeong
Young-Rae Lee
Eun-Mi Noh
Hyun Zo Youn
Sung Hoo Jung
Hong-Nu Yu
Eun Yong Chung
Jong-Suk Kim
Jeonbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of matrix metalloproteinases (MMPs) produced by cancer cells has been associated with the high potential of metastasis in several human carcinomas, including breast cancer. Several pieces of evidence demonstrate that protein tyrosine phosphatases (PTP) have functions that promote cell migration and metastasis in breast cancer. We analyzed whether PTP inhibitor might control breast cancer invasion through MMP expression. Herein, we investigate the effect of 4-hydroxy-3,3-dimethyl-2H benzo[g]indole-2,5(3H)-dione (BVT948), a novel PTP inhibitor, on 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced MMP-9 expression and cell invasion in MCF-7 cells. The expression of MMP-9 and cell invasion increased after TPA treatment, whereas TPA-induced MMP-9 expression and cell invasion were decreased by BVT948 pretreatment. Also, BVT948 suppressed NF-κB activation in TPA-treated MCF-7 cells. However, BVT948 didn't block TPA-induced AP-1 activation in MCF-7 cells. Our results suggest that the PTP inhibitor blocks breast cancer invasion via suppression of the expression of MMP-9.

Indexed as

Gene Expression Regulation, EnzymologicBreast NeoplasmsCarcinogensCell MovementCell SurvivalFemaleHumansIndolesMatrix Metalloproteinase 9MCF-7 CellsMitogen-Activated Protein KinasesNF-kappa BProtein Tyrosine PhosphatasesTetradecanoylphorbol AcetateTranscription Factor AP-14-hydroxy-3,3-dimethyl-2H-benzo(g)indole-2,5(3H)-dioneCarcinogensIndolesMatrix Metalloproteinase 9Mitogen-Activated Protein KinasesNF-kappa BProtein Tyrosine PhosphatasesTetradecanoylphorbol AcetateTranscription Factor AP-1

Identifiers

PMID24152909
PMCPMC4133842
OpenAlexW2071291589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.